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Introduction {#sec005}
============

Forest fires from farmers who use the 'slash-and-burn' technique for clearing land for agriculture result in seasonal haze that affects large parts of Southeast Asia for several months of the year.\[[@pone.0208724.ref001]\] The commonly afflicted countries include Singapore, Malaysia, Thailand and Indonesia. These forest fires have been of serious concern in view of their socioeconomic and political impact.\[[@pone.0208724.ref002]\] During the severe haze crises in 1997 and 2006, estimated economic losses attributable to the haze were US\$9 million and US\$50 million, respectively.\[[@pone.0208724.ref003], [@pone.0208724.ref004]\] These were largely due to decreased tourism, reduced efficiency in manufacturing and construction (industries involving largely outdoor work), and reduced human productivity (increased sick leave).\[[@pone.0208724.ref005]\]

Besides socioeconomic and political concerns, the health impact of the haze is also of equal importance. While long-term exposure to air pollution is known to have adverse impact on population health, the effects of short-term exposure to season haze (which only occurs for a few months in a year and has different contents than usual pollution) have not been clearly established. A previous study demonstrated negative impacts of the seasonal haze, which included increased frequency of emergency attendances for respiratory symptoms such as cough, sore throat and acute exacerbations of chronic obstructive airway disease.\[[@pone.0208724.ref006]\] Interestingly, extent of the air pollution correlated with the severity and frequency of symptoms experienced by the exposed population.\[[@pone.0208724.ref007], [@pone.0208724.ref008]\]

While the respiratory symptoms and irritation in eyes may be reported by the population exposed to higher concentrations of air pollutants, mechanisms for various non-specific symptoms like headache, lethargy, insomnia and other psychological symptoms are difficult to explain. Some studies postulated these symptoms to be related to changes in blood pressure and cerebral hemodynamics.\[[@pone.0208724.ref009], [@pone.0208724.ref010]\] Perceived dangerous pollutant standards index (PSI) values by susceptible individuals is also associated with negative psychological stress and symptoms.\[[@pone.0208724.ref011]--[@pone.0208724.ref013]\] In this opportunistic study, we investigated the effect of acute short-term haze exposure on cerebral hemodynamics in healthy individuals, in addition to the relationship between haze exposure and various psychosomatic symptoms. Psychosomatic symptoms were defined as physical and psychological symptoms commonly encountered during a haze crisis as previously studied by The Southeast Asian Haze Research Consortium.\[[@pone.0208724.ref011]\] We hypothesised that vasoactive substances present in the haze would cause vasodilation of cerebral vasculature and the altered cerebral hemodynamics might result in various psychosomatic symptoms.

Methods {#sec006}
=======

This study was conducted on healthy volunteers during a phase of 'seasonal haze' in Singapore during 2015. We excluded the participants who were older than 55 years of age to minimize the potential confounding effect of co-existing atherosclerosis or undetected cerebrovascular disease on their cerebral hemodynamics.\[[@pone.0208724.ref014]\] Baseline demographic and presence of previous medical conditions (hypertension, diabetes mellitus, hypercholesterolemia and migraine) were recorded. Two brachial artery blood pressure recordings were obtained from each arm using an automated cuff while participants were seated comfortably, and the higher reading was used for the systolic blood pressure, diastolic blood pressure and heart rate. Any new psychosomatic symptoms experienced by the subjects after 30 minutes of haze exposure were also captured using an anonymized standardized questionnaire, which included commonly experienced symptoms during the haze (sore throat, nausea, anxiety, insomnia, poor appetite, headache, neck stiffness, cough, sputum, breathlessness, runny nose, joint pain, rash, lethargy, itching and watery eyes). End-tidal CO2 (EtCO2) was measured with a capnometer (TIDAL Wave Sp Model 715; Novametrix, Wallingford, CT). All participants were asked to breathe through a plastic tube at the time of testing (beginning and at the end of breath holding test). The capnometer was used for the measurement of EtCO2 in both indoor and outdoor haze air.

All study participants were living in Singapore and working in the Western region of Singapore during the conduct of the study. They had not travelled abroad in the preceding 2 weeks, and had a minimum exposure of 2 weeks of 'seasonal haze' before participating in the study.

Written informed consent was obtained from all participants prior to the enrolment. Ethics approval was obtained from the Domain Specific Review Board (DSRB), Office of Human Research Protection Programme, National Healthcare Group (NHG), prior to the initiation of this study (NHG/DSRB Reference number 2014/00602). This study was performed in accordance with the guidelines of the Declaration of Helsinki and Belmont Report.

Transcranial Doppler (TCD) {#sec007}
--------------------------

Cerebral hemodynamics was evaluated with Digi-lite (Rimed Ltd, Israel) TCD system, which employs 2-MHz pulsed wave ultrasound to evaluate the blood flow characteristics in major intracranial arteries. TCD studies were performed by experienced sonographers, credentialed by the American Society of Neuroimaging. We obtained the optimal blood flow parameters from bilateral middle cerebral arteries (MCA), which was defined as the strongest flow signal obtained at a depth of 45--60 mm (sample volume 8mm).\[[@pone.0208724.ref015]\] Other major intracranial arteries were excluded, to minimise the time spent during the evaluation, specifically during outdoors in haze conditions. The recorded TCD parameters included peak systolic velocity (PSV), end-diastolic velocity (EDV) and mean flow velocity (MFV) in centimetres per second (cm/s). Cerebrovascular resistance index (CVRi) (mmHg/cms^-1^) was calculated by mean arterial pressure (mmHg) / mean flow velocity (cm/s) whereby mean arterial pressure = 2/3 × diastolic blood pressure + 1/3 × systolic blood pressure.\[[@pone.0208724.ref010]\] Pulsatility index (PI) was calculated for each side as peak systolic velocity---end diastolic velocity) / mean flow velocity.\[[@pone.0208724.ref015]\] PI represents the flow characteristics in the insonated artery.\[[@pone.0208724.ref016]\] Resistivity index (RI), which is calculated by (peak systolic velocity---end diastolic velocity) / peak systolic velocity was also calculated.\[[@pone.0208724.ref017]\] Being ratios, PI and RI are not affected by sonographers' technical experience or angle of TCD insonation. Breath-holding index (BHI) represents the vasodilatory reserve in the vascular bed supplied by the index artery.\[[@pone.0208724.ref018]\] It was calculated for bilateral MCAs in all study participants, according to a validated standardised method at our neurovascular laboratory.\[[@pone.0208724.ref019]\] Briefly, the Probe Holder LMY-3 (Rimed Ltd, Israel) was used to fix the TCD monitoring probes for bilateral MCA. Subjects were asked to hold breath for 30 seconds and MFVs in the MCAs were monitored. BHI was calculated as \[(MFVend of breath holding---MFV~baseline~)/MFV~baseline~) x 100/number of seconds of breath-holding\].\[[@pone.0208724.ref018]\] A value of \>0.69 represented normal BHI. All TCD evaluations were repeated outdoors after the study participants had spent at least 30 minutes in the haze environment.

Pollutant standards index (PSI) {#sec008}
-------------------------------

PSI was developed by the United States Environmental Protection Agency to describe the air quality. It was measured using five pollutants (carbon monoxide, sulfur dioxide, nitrogen dioxide, ozone and fine particles \<10micrometers (PM10)).\[[@pone.0208724.ref020]\] It ranges from 0--500 and is grades the air quality as good (0--50), moderate (51--100), unhealthy (101--200), very unhealthy (201--300), and hazardous for health (\>300).\[[@pone.0208724.ref020], [@pone.0208724.ref021]\] The ambient air in Singapore is monitored through a comprehensive network of air monitoring stations located in different regions of Singapore, which is administered by the National Environment Agency (NEA).\[[@pone.0208724.ref022]\] The PSI for the Western region of Singapore was monitored and released by NEA on an hourly basis during the study period. The prevailing region-specific PSI reading at the point of haze exposure was recorded by our study investigators to perform further statistical analyses.

Statistical analyses {#sec009}
--------------------

Continuous variables were summarized as means ±SD or medians (and interquartile ranges), and categorical variables as proportions. PSI level experienced between symptomatic and asymptomatic participants were analysed by independent t-test while EtCO2 levels in indoor and outdoor haze air were analysed with paired t-test. The effects of haze exposure and presence of symptoms in study participants (1 or more new symptoms that started with haze exposure) on cerebral hemodynamics were analysed with the use of two-way repeated measures analysis of variance (ANOVA). Post hoc test was carried out for significant interactions. We also employed a linear regression to evaluate the correlation of mean PI and RI with the number of new symptoms experienced and the PSI value, quantified by Pearson's correlation coefficient (r). Mean PI or RI were obtained by calculating the mean of the left and right MCA corresponding values. A p-value of less than 0.05 was considered as statistically significant. All data was analysed using IBM SPSS Statistics version 20.

Results {#sec010}
=======

Seventy-four healthy volunteers were enrolled in this study. The median age was relatively young (30 years, IQR 26--34). Most of the subjects were Chinese, while the rest were Indian, Malay, Filipino or from other ethnicities. Owing to the young population, the prevalence of medical comorbidities including hypertension, hypercholesterolemia and diabetes mellitus were expectedly low in our study ([Table 1](#pone.0208724.t001){ref-type="table"}). In our study population, 35 (47.3%) participants developed new symptoms after haze exposure. Headache and lethargy were the most common symptoms encountered.

10.1371/journal.pone.0208724.t001

###### Baseline characteristics of study participants (n = 74).

![](pone.0208724.t001){#pone.0208724.t001g}

  Characteristic                
  ----------------------------- -------------
  Median age, years (IQR)       30 (26--34)
  Female sex, n (%)             45 (60.8%)
  Ethnicity, n (%)              
   Chinese                      43 (58.1%)
   Indian                       12 (16.2%)
   Malay                        5 (6.8%)
   Filipino                     11 (14.9%)
   Others                       3 (4.1%)
  Hypertension, n (%)           4 (5.4%)
  Hypercholesterolemia, n (%)   3 (4.1%)
  Diabetes Mellitus, n (%)      3 (4.1%)
  Smoker, n (%)                 4 (5.4%)
  Migraine, n (%)               8 (10.8%)

The baseline EtCO2 in outdoor haze air (38.1±0.9 mmHg) was higher than in indoor air (35.8±0.7 mmHg, p\<0.001). Mean outdoor haze PSI level experienced by our study participants was 116±39 units. While 36 (48.6%) were exposed to the moderate range (51--100), 38 (51.4%) participants experienced haze in the unhealthy range (PSI 101--200). In the asymptomatic group, 20 participants (51.3%) were exposed to haze in the moderate range, while 19 participants (48.7%) experienced haze in the unhealthy range. In the symptomatic group, 16 participants (45.7%) were exposed to haze in the moderate range, while 19 participants (54.3%) experienced haze in the unhealthy range. Overall, there was no significant difference (p = 0.729) in PSI level experienced between symptomatic (118±40 units) and asymptomatic participants (115±39 units).

Effects of haze exposure on cerebral hemodynamics {#sec011}
-------------------------------------------------

The effect of outdoor haze exposure and presence of symptoms experienced by participants on TCD findings and vital signs are shown in [Table 2](#pone.0208724.t002){ref-type="table"}. There was a statistically significant effect of haze exposure on PI and RI values in the left MCA (PI: p = 0.026; RI: p = 0.021) and the mean MCA (PI: p = 0.021; RI, p = 0.015), but only RI value in the right MCA (RI, p = 0.046). There were no significant differences in PSV, EDV, MFV, CVRi or BHI observed after haze exposure in bilateral MCAs ([Table 2](#pone.0208724.t002){ref-type="table"}).

10.1371/journal.pone.0208724.t002

###### ANOVA repeated measures analysis (n = 74) stratifying groups into asymptomatic (n = 39) and symptomatic (n = 35) volunteers.

![](pone.0208724.t002){#pone.0208724.t002g}

  Haemodynamic Parameter                            Baseline       After Haze Exposure   Mean difference (95% CI)   Haze Exposure (within group)   Symptoms (between group)   Haze\*Symptoms   Post Hoc                          
  ------------------------------------------------- -------------- --------------------- -------------------------- ------------------------------ -------------------------- ---------------- ------------- ------- ----------- -----------
  Left MCA                                                                                                                                                                                                                       
  Mean flow velocity, cm/s (mean, SD)                                                                                                                                                                                            
   Asymptomatic                                     61.8 (11.5)    60.0 (9.9)            -1.8 (-4.8--1.2)           0.005                          0.942                      3.544            0.064         2.230   0.140       N/A
   Symptomatic                                      64.8 (13.0)    66.5 (13.6)           1.7 (2.1--5.4)                                                                                                                          
  Peak systolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     100.0 (19.4)   97.1 (16.3)           -2.9 (-7.8--2.1)           0.726                          0.397                      1.933            0.169         0.644   0.425       N/A
   Symptomatic                                      104.3 (20.4)   104.2 (20.4)          -0.09 (-5.1--4.9)                                                                                                                       
  End diastolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     42.7 (7.9)     41.4 (6.9)            -1.3 (-3.6--1.0)           0.649                          0.423                      6.527            **0.013**     4.583   **0.036**   0.335
   Symptomatic                                      45.3 (9.8)     48.2 (10.9)           2.9 (-0.5--6.2)                                                                                                                         **0.046**
  Cerebrovascular resistance index (mmHg/cms^-1^)                                                                                                                                                                                
   Asymptomatic                                     1.47 (0.33)    1.52 (0.30)           0.05 (-0.05--0.14)         0.436                          0.511                      0.391            0.534         0.604   0.440       N/A
   Symptomatic                                      1.45 (0.33)    1.44 (0.41)           -0.004 (-0.10--0.09)                                                                                                                    
  Pulsatility index                                                                                                                                                                                                              
   Asymptomatic                                     0.93 (0.08)    0.93 (0.07)           0.004 (-0.03--0.04)        5.138                          **0.026**                  8.326            **0.005**     6.518   **0.013**   0.836
   Symptomatic                                      0.91 (0.10)    0.85 (0.10)           -0.06 (-0.11 ---0.02)                                                                                                                   **0.001**
  Resistivity index                                                                                                                                                                                                              
   Asymptomatic                                     0.57 (0.03)    0.57 (0.03)           0.002 (-0.01--0.01)        5.612                          **0.021**                  11.13            **0.001**     7.065   **0.010**   0.834
   Symptomatic                                      0.57 (0.04)    0.54 (0.04)           -0.03 (-0.04 ---0.01)                                                                                                                   **0.001**
  Breath holding index                                                                                                                                                                                                           
   Asymptomatic                                     1.6 (0.6)      1.6 (0.6)             -0.05 (-0.25--0.14)        0.000                          0.983                      0.093            0.761         0.596   0.443       N/A
   Symptomatic                                      1.6 (0.5)      1.7 (0.5)             0.05 (-0.15--0.25)                                                                                                                      
  Right MCA                                                                                                                                                                                                                      
  Mean flow velocity, cm/s (mean, SD)                                                                                                                                                                                            
   Asymptomatic                                     59.3 (9.9)     60.7 (11.4)           1.4 (-2.4--5.1)            1.922                          0.170                      1.453            0.232         0.089   0.767       N/A
   Symptomatic                                      61.8 (13.1)    63.9 (12.3)           2.1 (-1.3--5.6)                                                                                                                         
  Peak systolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     96.6 (17.0)    98.6 (17.3)           1.9 (-3.5--7.4)            0.615                          0.435                      0.104            0.748         0.074   0.786       N/A
   Symptomatic                                      98.4 (20.6)    99.3 (18.9)           0.94 (-4.1--6.0)                                                                                                                        
  End diastolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     40.6 (6.6)     41.8 (8.6)            1.2 (-1.6--4.0)            3.292                          0.074                      4.291            **0.042**     0.453   0.503       N/A
   Symptomatic                                      43.5 (9.7)     46.1 (9.6)            2.6 (-0.6--5.7)                                                                                                                         
  Cerebrovascular resistance index (mmHg/cms^-1^)                                                                                                                                                                                
   Asymptomatic                                     1.51 (0.28)    1.51 (0.30)           -0.01 (-0.10--0.09)        0.931                          0.338                      0.005            0.943         0.557   0.458       N/A
   Symptomatic                                      1.55 (0.46)    1.49 (0.34)           -0.06 (-0.17--0.05)                                                                                                                     
  Pulsatility index                                                                                                                                                                                                              
   Asymptomatic                                     0.94 (0.07)    0.94 (0.08)           0.00 (-0.03--0.03)         3.520                          0.065                      19.71            **\<0.001**   3.404   0.069       N/A
   Symptomatic                                      0.89 (0.10)    0.84 (0.13)           -0.05 (-0.10---0.003)                                                                                                                   
  Resistivity index                                                                                                                                                                                                              
   Asymptomatic                                     0.58 (0.03)    0.58 (0.03)           0.00 (-0.01--0.01)         4.141                          **0.046**                  19.44            **\<0.001**   3.424   0.068       N/A
   Symptomatic                                      0.56 (0.04)    0.53 (0.05)           -0.02 (-0.04 ---0.002)                                                                                                                  
  Breath holding index                                                                                                                                                                                                           
   Asymptomatic                                     1.6 (0.4)      1.5 (0.5)             -0.07 (-0.22--0.09)        0.346                          0.558                      1.755            0.189         0.293   0.590       N/A
   Symptomatic                                      1.7 (0.6)      1.7 (0.5)             -0.003 (-0.20--0.19)                                                                                                                    
  Mean MCA                                                                                                                                                                                                                       
  Mean flow velocity, cm/s (mean, SD)                                                                                                                                                                                            
   Asymptomatic                                     60.5 (9.4)     60.3 (9.3)            0.23 (-2.2--2.7)           0.783                          0.379                      2.780            0.100         1.263   0.265       N/A
   Symptomatic                                      63.3 (11.9)    65.2 (12.2)           -1.9 (-4.9--1.1)                                                                                                                        
  Peak systolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     98.3 (16.2)    97.8 (14.8)           0.46 (-3.2--4.2)           0.000                          0.990                      0.873            0.353         0.118   0.733       N/A
   Symptomatic                                      101.3 (18.6)   101.8 (18.2)          -0.4 (-4.2--3.3)                                                                                                                        
  End diastolic velocity, cm/s (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     41.7 (6.2)     41.6 (6.9)            0.06 (-1.8--2.0)           2.522                          0.117                      6.217            **0.015**     2.770   0.100       N/A
   Symptomatic                                      44.4 (8.9)     47.1 (9.7)            -2.7 (-5.6--0.17)                                                                                                                       
  Cerebrovascular resistance index (mmHg/cms^-1^)                                                                                                                                                                                
   Asymptomatic                                     1.49 (0.27)    1.51 (0.27)           0.02 (-0.05--0.09)         0.060                          0.808                      0.087            0.769         1.170   0.283       N/A
   Symptomatic                                      1.50 (0.36)    1.47 (0.35)           -0.03 (-0.10--0.04)                                                                                                                     
  Pulsatility index                                                                                                                                                                                                              
   Asymptomatic                                     0.93 (0.06)    0.94 (0.07)           0.002 (-0.03--0.03)        5.568                          **0.021**                  16.66            **\<0.001**   6.250   **0.015**   0.919
   Symptomatic                                      0.90 (0.10)    0.84 (0.10)           -0.06 (-0.10 ---0.02)                                                                                                                   **0.001**
  Resistivity index                                                                                                                                                                                                              
   Asymptomatic                                     0.57 (0.02)    0.57 (0.03)           0.00 (-0.01--0.01)         6.196                          **0.015**                  18.22            **\<0.001**   6.453   **0.013**   0.970
   Symptomatic                                      0.56 (0.04)    0.54 (0.04)           0.02 (-0.04 ---0.01)                                                                                                                    **0.001**
  Breath holding index                                                                                                                                                                                                           
   Asymptomatic                                     1.60 (0.47)    1.54 (0.48)           0.06 (-0.07--0.20)         0.149                          0.701                      0.762            0.386         0.785   0.379       N/A
   Symptomatic                                      1.64 (0.49)    1.66 (0.41)           -0.02 (-0.17--0.12)                                                                                                                     
  Vital Signs                                                                                                                                                                                                                    
  Systolic blood pressure, mmHg (mean, SD)                                                                                                                                                                                       
   Asymptomatic                                     118.6 (11.0)   117.6 (10.8)          -0.97 (-4.2--2.3)          0.917                          0.341                      1.811            0.183         0.004   0.949       N/A
   Symptomatic                                      121.8 (10.2)   120.7 (12.5)          -1.1 (-4.0--1.9)                                                                                                                        
  Diastolic blood pressure, mmHg (mean, SD)                                                                                                                                                                                      
   Asymptomatic                                     72.0 (7.3)     74.0 (6.6)            2.0 (-0.3--4.3)            6.066                          **0.016**                  2.427            0.124         0.027   0.870       N/A
   Symptomatic                                      74.5 (9.6)     76.8 (9.7)            2.3 (-0.4--5.0)                                                                                                                         
  Heart rate, beats per minute (mean, SD)                                                                                                                                                                                        
   Asymptomatic                                     76.4 (14.5)    79.4 (13.2)           3.0 (-0.4--6.4)            5.427                          **0.023**                  0.139            0.710         0.048   0.828       N/A
   Symptomatic                                      77.6 (8.1)     80.1 (11.6)           2.5 (-0.8--5.8)                                                                                                                         

In terms of changes in the vital signs after haze exposure, the effect of haze exposure was significant on diastolic blood pressure (p = 0.016) and heart rate (p = 0.023), but the systolic blood pressure remained similar (p = 0.341) ([Table 2](#pone.0208724.t002){ref-type="table"}).

Subgroup analyses---Asymptomatic and symptomatic groups {#sec012}
-------------------------------------------------------

Subgroup analyses showed no significant differences in PSV, MFV, CVRi or BHI within and between the symptomatic and asymptomatic groups ([Table 2](#pone.0208724.t002){ref-type="table"}). However, there were statistically significant interactions between the effects of haze exposure and presence of symptoms on EDV (p = 0.036), PI (p = 0.013) and RI (p = 0.010) values in the left MCA. These significant interactions were not replicated in the right MCA. Significant interactions were also found on PI and RI in mean MCA (mean MCA PI: p = 0.015; and mean MCA RI: p = 0.013). All study participants were young individuals who did not suffer from any pulmonary disease. EtCO2 increased equally in both symptomatic and asymptomatic subjects. Therefore, it was not included in ANOVA and post hoc tests.

Results of post hoc test performed for significant interactions were reported ([Table 2](#pone.0208724.t002){ref-type="table"}). Of note, haze exposure resulted in significantly lower mean PI (p = 0.001) and RI (p = 0.001) values in symptomatic patients, but this difference was not present in asymptomatic patients (PI: p = 0.919; RI: p = 0.970) ([S1](#pone.0208724.s001){ref-type="supplementary-material"} and [S2](#pone.0208724.s002){ref-type="supplementary-material"} Figs).

Correlating PI and RI with symptoms {#sec013}
-----------------------------------

We demonstrated a negative correlation between mean MCA PI and the number of psychosomatic symptoms, where the higher the number of psychosomatic symptoms experienced, the lower the mean MCA PI (r = -0.519, p\<0.001). A similar relationship was observed when studying the correlation between mean MCA RI and the number of psychosomatic symptoms participants had experienced (r = -0.538, p\<0.001) ([Fig 1](#pone.0208724.g001){ref-type="fig"}).

![Scatter plot showing the correlation between mean middle cerebral artery pulsatility index (PI) and resistivity index (RI), and number of psychosomatic symptoms.](pone.0208724.g001){#pone.0208724.g001}

Correlating PI and RI with PSI {#sec014}
------------------------------

A statistically significant negative correlation was found when evaluating both mean MCA PI and RI with PSI levels (PI: r = -0.339, p = 0.003; RI: r = -0.345, p = 0.003) ([Fig 2](#pone.0208724.g002){ref-type="fig"}).

![Scatter plot showing the correlation between mean middle cerebral artery pulsatility index (PI) and resistivity index (RI), and pollutant standards index (PSI).](pone.0208724.g002){#pone.0208724.g002}

Discussion {#sec015}
==========

The main findings of our study are: (1) There was a modest but significant decrease in PI and RI in the left MCA after haze exposure, along with notable decreases in PI and RI after haze exposure in the right MCA showing a trend towards significance but, perhaps because of a small sample size, did not achieve statistical significance; (2) On subgroup analyses, the differences in mean PI and RI values after haze exposure were pronounced in the symptomatic group; (3) Participants who reported new psychosomatic symptoms during haze exposure developed a significant decrease in PI and RI on TCD while the asymptomatic volunteers did not show any significant change in these TCD parameters. We postulate that participants could have had different susceptibility to the vasoactive effect of haze constituents on their cerebral vasculature.

TCD is a non-invasive bed-side tool that enables a reliable assessment of cerebral hemodynamics. It allows continuous monitoring of the blood flow in major intracranial arteries, which allows the evaluation of the impact of various vasoactive stimuli and challenges. For example, MFV and PI have been used in traumatic brain injury and subarachnoid hemorrhage as a surrogate measure of cerebral vasospasm and raised intracranial pressure, respectively.\[[@pone.0208724.ref023]--[@pone.0208724.ref025]\] PI represents the inherent resistance to the blood flow in an artery, influenced by the nature and stiffness of the brain vessels as well as compliance of the surrounding brain parenchyma.\[[@pone.0208724.ref026]\] PI may be reduced if the vascular bed distal to the site of insonation develops vasodilation; increased carbon-dioxide being the strongest trigger.\[[@pone.0208724.ref018]\] RI is another TCD parameter sometimes used to assess the flow resistance, it represents flow resistance distal to the site of insonation.\[[@pone.0208724.ref018]\] A decrease in PI and RI represents cerebral vasodilation due to the ambient haze exposure. These findings were most prominent after haze exposure amongst the individuals who reported new symptoms. The most common symptoms experienced were headache and lethargy, where changes in cerebral hemodynamics appear to play an important role. In general, both PI and RI represent similar information about the vascular resistance distal to the site of TCD insonation and are often used interchangeably.

Our findings suggest that exposure to short-term haze air, containing higher amount of carbon-dioxide and other vasoactive particulate matter, resulted in mild cerebral vasodilation. Similar reductions in the peripheral resistance have been demonstrated in the form of changes in brachial artery diameter, flow and elasticity.\[[@pone.0208724.ref027], [@pone.0208724.ref028]\] Cerebral blood flow is regulated, in part by the release of nitric oxide from vascular endothelial cells, and could be altered by levels and fluctuations of arterial carbon dioxide concentrations by a similar mechanism.\[[@pone.0208724.ref029], [@pone.0208724.ref030]\] Although we found a relationship between the level of haze and PI and RI, there was no significant change in BHI. Perhaps, this observation occurred due to our subjects being young and healthy. The changes in cerebral hemodynamics could have been more pronounced if we had included elderly individuals with various cardiovascular risk factors.\[[@pone.0208724.ref010]\] Similarly, no significant change in CVRi was found. This may also be attributed to the relatively young study population without cardiovascular risk factors, hence their autonomic nervous system would likely be able to maintain cerebrovascular resistance through various hemodynamic adjustments.\[[@pone.0208724.ref031]\] Lastly, the result could be a statistical error given the small sample size.

In addition to the TCD parameters, we report a statistically significant increase in diastolic blood pressure and heart rate after haze exposure. These may represent physiological changes in response to short-term haze exposure, which have higher concentrations of carbon dioxide. Peripheral and central chemoreceptors are sensitive to increases in arterial partial pressure of carbon dioxide. When these chemoreceptors are activated, they trigger an increase in heart rate, cardiac output and blood pressure via complex neural-hormonal pathways.\[[@pone.0208724.ref032], [@pone.0208724.ref033]\]

Certain limitations of our study need to be acknowledged. During the study period, the Ministry of Environment did not release the data for hourly PM2.5 sub-index, PM10 sub-index, Sulphur Dioxide sub-index, O3 sub-index, Carbon Monoxide sub-index and Nitrogen Dioxide. Thus, it is an inherent limitation of our study that we are unable to identify the precise constituents of the haze air that is responsible for the maximal hemodynamic effect on the cerebral vasculature. In addition, the exact period of haze exposure for each participant could not be standardised, which may result in exposure to different constituents of the haze or different past exposure to haze prior to the experiment. Nonetheless, this opportunistic study was performed to evaluate the real-world effects of cerebral hemodynamic changes from exposure to haze in its entirety, considering it to be vasoactive cumulatively. Importantly, our findings support a larger study with analyses of the concentration of the individual constituents of haze. We had initially planned to have subsequent air samples analysed for the concentrations of its specific constituents. However, due to the political efforts by various local and international government agencies, there was no opportunity to enable the planned study as there was no recurrence of a haze crisis of that magnitude in the region thereafter. Second, our prospective study focused on investigating the development of symptoms after short term haze exposure in healthy subjects. Our findings may not be extrapolated to older patients and with significant comorbidities like diabetes, hypertension and steno-occlusive disease of cervico-cranial large arteries etc, which may further exacerbate the harmful effects of haze exposure. Third, while we demonstrate the possible association between acute symptoms and cerebral hemodynamic responses, the long-term implications of such association remain unknown. Fourth, differences in the nature of particulate matter at different geographic locations may also mean that the findings of our study may not be generalizable to air pollution from other geographic locations. Lastly, the contents of haze caused by the annual forest fires in Southeast Asia may not be similar to the contents of polluted air. We did not record the information on the levels of particulate material of 2.5 micron or lower (PM~2.5~), considered to be vasoactive and responsible for many of the long-term somatic effects of polluted air. \[[@pone.0208724.ref034]--[@pone.0208724.ref036]\]

Conclusions {#sec016}
===========

Our study provides preliminary estimates of the effects of haze on cerebral hemodynamic parameters, which are probably associated with various psychosomatic symptoms. Even a short-term exposure to only moderately unhealthy haze conditions induced these changes in susceptible individuals. Perhaps, a larger study may determine the short-term impact of haze on individual work efficiency as well as long-term health effects of cerebral hemodynamic changes.

Supporting information {#sec017}
======================

###### Subgroup analyses showing mean middle cerebral artery pulsatility index (PI) change after haze exposure.

(JPG)

###### 

Click here for additional data file.

###### Subgroup analyses showing mean middle cerebral artery resistivity index (RI) change after haze exposure.

(JPG)

###### 

Click here for additional data file.

###### De-identified database.

(XLSX)

###### 

Click here for additional data file.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
